Universal Health Realty Income Trust (UHT) Stock Price & Analysis
Universal Health Realty Income Trust (UHT) closed at USD 37.81 on Thursday, October 22, 2026, up 2.41% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 36.92; the Oct 22, 2026 session ranged USD 36.9–38.01 on volume of 94,805 shares. Market capitalization is $525.51M, with a 52-week range of USD 35.69–46.3 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 11:44 UTC.
Also available as compact Markdown for AI agents: nexqual.com/UHT.md
Key facts (UHT)
- Last four reported quarters (through Jun 30, 2026): revenue $99.3M, net income $19.3M (19.4% margin) (SEC filings).
- Valuation: P/E 27.3x (avg 32.2x at the last 3 fiscal year-ends).
- Analysts: Hold (mean 3.00 on a 1–5 scale) (1 analysts), mean target USD 44 (range 44–44).
- Total return with dividends: 1Y +12.9% vs S&P 500 +14.9%; 5Y -8.2% vs S&P 500 +80.3%.
- Next earnings: 2026-10-26, EPS estimate USD —, revenue estimate $24.9M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (UHT)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $84.2M | $90.6M | $95.6M | $99.0M | $99.2M | $99.3M |
| Operating income | $28.9M | $30.7M | $31.3M | $36.8M | $34.8M | $35.0M |
| Net income | $109M | $21.1M | $15.4M | $19.2M | $17.6M | $19.3M |
| EPS (diluted) | $7.92 | $1.53 | $1.11 | $1.39 | $1.27 | — |
| Free cash flow | $34.7M | $33.2M | $35.3M | — | — | — |
| Operating margin | 34.3% | 33.8% | 32.8% | 37.2% | 35.0% | 35.3% |
| Net margin | 129.7% | 23.3% | 16.1% | 19.4% | 17.8% | 19.4% |
| Revenue growth | +7.9% | +7.6% | +5.5% | +3.6% | +0.2% | — |
| Cash + short-term investments | $22.5M | $7.6M | $8.2M | $7.1M | $6.7M | — |
| Total debt | $329M | $343M | $360M | $368M | $375M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (UHT)
P/E 27.3x · P/S 5.3x · P/B 3.6x · Earnings yield 3.67% · Dividend yield (paid, TTM) 7.88%
P/E at fiscal year-ends: Dec 2025 30.9x, Dec 2024 26.8x, Dec 2023 38.8x.
Analysts (UHT)
Consensus Hold (mean 3.00 on a 1–5 scale), 1 analysts; mean target USD 44 (low 44, high 44).
Total return (dividends reinvested) (UHT)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +12.9% | -8.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +13.0% | -1.7% |
| Volatility (annualized) | 23.3% | 25.6% |
| Max drawdown | -19.0% (Jul 2026→Oct 2026) | -36.8% (Feb 2022→Apr 2024) |
UHT suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | UNIVERSAL HEALTH SERVICES INC (UHS) | “Our officers are all employees of UHS through its wholly-owned subsidiary, UHS of Delaware, Inc. In addition, five of our hospital facilities are leased to wholly-owned subsidiaries of UHS, one of our hospital facilities is leased to a joint venture between a wholly-owned subsidiary of UHS and a third party, and subsidiaries of UHS are tenants of nineteen medical office buildings ("MOBs"), free-standing emergency …” |
Quoted from the company's 10-K filed Feb 25, 2026.
UHT company outlook (results filed Jul 27, 2026)
- “Construction of this MOB, for which we have engaged a wholly-owned subsidiary of UHS to act as project manager, commenced in February, 2026, and is expected to be completed in December, 2026.”
Quoted word-for-word from the SEC 8-K results press release.
UHT analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | — | — | — | $24.9M | — |
| Next quarter (ends Dec 2026) | — | — | — | $25.1M | — |
| Current fiscal year (ends Dec 2026) | — | — | — | $99.5M | — |
| Next fiscal year (ends Dec 2027) | — | — | — | $104.7M | — |
UHT options: expected move
Options price a move of about ±7.5% (±$2.85) by Nov 20, 2026, which includes earnings on Oct 26, 2026. Over the last 8 reports the stock moved ±1.6% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 54.4% | ±7.5% |
| Dec 18, 2026 | 56 | 21.5% | ±8.3% |
| Mar 19, 2027 | 147 | 30.3% | ±19.9% |
30-day implied volatility 25.3% vs 24.6% realized over the last 30 trading days. Put/call ratio (volume) 0. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 11:44 UTC)
| Price | USD 37.81 |
|---|---|
| Change | ▲ 2.41% (up) |
| Previous Close | USD 36.92 |
| Open | USD 37.26 |
| Day Range | USD 36.9 – 38.01 |
| 52-Week Range | USD 35.69 – 46.3 |
| Volume | 94,805 shares |
| Market Cap | $525.51M |
| Exchange | NYQ |
Technical Analysis (UHT)
Nexqual's technical model rates UHT "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of October 23, 2026 at 11:44 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 46.33 (neutral) |
| vs SMA50 | Below (USD 39.49) |
| MACD | -0.56 (negative) |
Analyst Ratings (UHT)
Wall Street analysts rate UHT "Hold" based on 1 analysts, with a mean price target of USD 44 (range USD 44–44), per Nexqual as of October 23, 2026 at 11:44 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 44 |
| High Target | USD 44 |
| Low Target | USD 44 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (UHT)
| Next Earnings Date | 2026-10-26 |
|---|---|
| Revenue Estimate | $24.90M |
Source: Nexqual, October 23, 2026 at 11:44 UTC.
Financials & Fundamentals (UHT)
| Total Revenue | $101.15M |
|---|---|
| Revenue Growth (latest quarter, YoY) | +0.70% |
| Gross Margin | +94.39% |
| Operating Margin | +37.89% |
| Profit Margin | +19.05% |
| ROE | +12.47% |
| Debt / Equity | 2.75 |
| Current Ratio | 7.37 |
| Total Cash | $9.42M |
| Total Debt | $395.10M |
Source: Nexqual, October 23, 2026 at 11:44 UTC.
Financial Health Score (UHT)
Nexqual rates Universal Health Realty Income Trust's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 11:44 UTC.
| Growth | Mixed — Revenue +0.7% YoY (latest Q), slow |
|---|---|
| Profitability | Strong — Gross margin 94%, operating 38% (last 12 months) |
| Balance Sheet | Weak — $7M cash and investments vs $375M debt (Dec 2025, SEC) |
| Cash Flow | Solid — Operating cash flow $49M (FY ended Dec 2025, 10-K) |
| Efficiency | Mixed — ROE 12%, ROA 4.1% |
Ownership (UHT)
| Insider Ownership | +8.36% |
|---|---|
| Institutional Ownership | +63.42% |
| Shares Outstanding | 13.90M |
| Float | 12.77M |
| Short % of Float | +3.85% |
Source: Nexqual, October 23, 2026 at 11:44 UTC.
Leadership (UHT)
Universal Health Realty Income Trust is led by Alan B. Miller, Chairman, President & CEO, per Nexqual as of October 23, 2026 at 11:44 UTC.
| Chairman, President & CEO | Alan B. Miller |
|---|---|
| Senior VP & CFO | Charles F. Boyle |
| Vice President of Acquisitions & Development | Karla J. Peterson |
Major Backers & Investors (UHT)
Notable institutional backers of Universal Health Realty Income Trust include GLOBAL X FUNDS-Global X SuperDividend U.S. ETF, Mirae Asset Global ETFs Holdings Ltd., Jane Street Group, LLC, according to Nexqual as of October 23, 2026 at 11:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| GLOBAL X FUNDS-Global X SuperDividend U.S. ETF | 2.57% |
| Mirae Asset Global ETFs Holdings Ltd. | 2.54% |
| Jane Street Group, LLC | 1.92% |
| Two Sigma Investments, LP | 1.65% |
| Qube Research & Technologies Ltd | 1.49% |
| Citadel | 1.44% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 10.74% |
| Vanguard Group | 10.12% |
| State Street | 2.72% |
| Geode Capital | 2.7% |
Source: Nexqual, October 23, 2026 at 11:44 UTC.
From Universal Health Realty Income Trust's Latest SEC 10-K Filing (filed 2026-02-25)
Partnerships
- In connection with this MOB, we entered into a ground lease and master flex-lease agreement with a wholly-owned subsidiary of UHS both of which commenced during March, 2023.
- The Advisory Agreement was renewed for 2026 with the same terms as the Advisory Agreement in place during 2025, 2024 and 2023.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XRN | Chiron Real Estate Inc. | USD 30.16 | ▲ 4.61% |
| CHCT | Community Healthcare Trust Inco | USD 12.93 | ▲ 2.29% |
| MPT | Medical Properties Trust, Inc. | USD 2.71 | ▲ 3.04% |
| DHC | Diversified Healthcare Trust | USD 7.87 | ▲ 2.34% |
| LTC | LTC Properties, Inc. | USD 43.33 | ▲ 2.7% |
| NHI | National Health Investors, Inc. | USD 66.96 | ▲ 3.14% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 11:44 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt